Bandingkan Harga & Kinerja Sumi Indo Kabel Tbk. (IKBI) vs Indofarma Tbk. (INAF)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Sumi Indo Kabel Tbk. dan Indofarma Tbk.: Sumi Indo Kabel Tbk. diperdagangkan di Rp555 (kapitalisasi pasar 691,56 M, volume 24 jam 1,4 jt), sedangkan Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M). Perbedaan utamanya: Sumi Indo Kabel Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| IKBI | INAF | |
|---|---|---|
Kapitalisasi Pasar | 691,56 M | 390,51 M |
Volume | 1,4 jt | — |
Lot | 14,02 rb | — |
Perputaran | 779,16 jt | — |
Harga Rata-rata | 555,91 | — |
Nilai Transaksi | 779,16 jt | — |
Harga Ekuilibrium Indikatif | 555 | — |
Volume Ekuilibrium Indikatif | 49 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Sumi Indo Kabel Tbk.
The Company was established on July 23, 1981 with its Head Office and Factory located in Tangerang, West Java. The Company was listed in JSX and SSX in 1990. On 1994 the Company changed status of the Company to become Foreign Capital Investment (PMA), right after participation of Sumitomo Electric Industries, Ltd., Japan which is one of the biggest in the world in cable industry and PT Perdanamulia Ekasakti.
Selengkapnya di halaman IKBI →Tentang Indofarma Tbk.
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Selengkapnya di halaman INAF →
